Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Paracetamol 1g/5ml oral liquid
0407010H0AACSCS
|
Paracetamol | Paracetamol | Central Nervous System | No data available |
|
Paracetamol 240mg oral powder sachets sugar free
0407010H0AAA8A8
|
Paracetamol | Paracetamol | Central Nervous System | No data available |
|
Paracetamol 500mg / Caffeine 65mg tablets
0407010U0AAAAAA
|
Paracetamol/caffeine | Paracetamol and caffeine | Central Nervous System | No data available |
|
Paracetamol 500mg / Domperidone 10mg tablets
0407041A0AAAIAI
|
Analgesics with anti-emetics | Analgesics with anti-emetics | Central Nervous System | No data available |
|
Paracetamol 500mg / Ibuprofen 150mg tablets
0407010ADAAABAB
|
Paracetamol/ibuprofen | Paracetamol and ibuprofen | Central Nervous System | No data available |
|
Paracetamol 500mg / Phenylephrine 12.18mg capsules
0407010ABAAACAC
|
Paracetamol/phenylephrine hydrochloride | Paracetamol and phenylephrine hydrochloride | Central Nervous System | No data available |
|
Paracetamol 500mg / Phenylephrine 6.1mg tablets
0407010ABAAADAD
|
Paracetamol/phenylephrine hydrochloride | Paracetamol and phenylephrine hydrochloride | Central Nervous System | No data available |
|
Paracetamol 500mg / Pseudoephedrine hydrochloride 60mg tab
0310000N0AAAUAU
|
Pseudoephedrine hydrochloride | Pseudoephedrine hydrochloride | Respiratory System | No data available |
|
Paracetamol 500mg oral powder sachets
0407010H0AADRDR
|
Paracetamol | Paracetamol | Central Nervous System | No data available |
|
Paracetamol 500mg/50ml solution for infusion bottles
0407010H0AADTDT
|
Paracetamol | Paracetamol | Central Nervous System | No data available |
|
Paracetamol 50mg oral powder sachets sugar free
0407010H0AADQDQ
|
Paracetamol | Paracetamol | Central Nervous System | No data available |
|
Paracetamol 650mg / Ascorbic acid 50mg oral powder sachets
0407010X0AAAZAZ
|
Paracetamol combined preparations | Paracetamol combined preparations | Central Nervous System | No data available |
|
Paracetamol 650mg oral powder sachets
0407010H0AADMDM
|
Paracetamol | Paracetamol | Central Nervous System | No data available |
|
Paracets 500mg capsules
0407010H0BWAAAA
|
Paracets | Paracetamol | Central Nervous System | No data available |
|
Paracodol 8mg/500mg capsules
0407010F0BBAAAB
|
Paracodol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Paracodol 8mg/500mg effervescent tablets
0407010F0BBABAC
|
Paracodol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Paradote 100mg/500mg tablets
040701020BBAAAA
|
Paradote | Co-methiamol (Methionine/paracetamol) | Central Nervous System | No data available |
|
Paradox Omega 3 Cardio TG capsules
091200000BFSEA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Paradox Omega capsules
091200000BFSDA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Paradox Omega liquid
090607000BBLKA0
|
Proprietary compound preparation BNF 0906070 | Other multivitamin preparations | Nutrition and Blood | No data available |
|
Paraffin hard MP 43-46C solid
1301010P0AAABAB
|
Paraffin Hard | Paraffin hard | Skin | No data available |
|
Paraffin hard MP 45-50C solid
1301010P0AAACAC
|
Paraffin Hard | Paraffin hard | Skin | No data available |
|
Paragauze dressing 10cm x 10cm
20040200635
|
Paragauze dressing 10cm x 10cm | Gauzes & Gauze Tissue | Dressings | No data available |
|
Paraldehyde 100% solution for injection 5ml ampoules
0408020Q0AAACAC
|
Paraldehyde | Paraldehyde | Central Nervous System | No data available |
|
Paraldehyde 50% in Arachis oil rectal solution
0408020Q0AAAHAH
|
Paraldehyde | Paraldehyde | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.